218 related articles for article (PubMed ID: 10945172)
21. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Srivastava P; Pandey VC
Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
[TBL] [Abstract][Full Text] [Related]
22. Methemoglobin formation in the blood of Japanese subjects and mice suffering from acatalasemia in response to methemoglobin inducers.
Ogata M; Ishii K; Ioku N; Meguro T
Physiol Chem Phys Med NMR; 1990; 22(3):125-34. PubMed ID: 2093192
[TBL] [Abstract][Full Text] [Related]
23. [Oxidative damage of mice erythrocytes infected with Plasmodium berghei].
Grieger M; Siems W; Müller M; Grinberg L; Leppin K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):581-93. PubMed ID: 6196273
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
25. Effect of stress conditions on the course of trophozoite-induced Plasmodium yoelii nigeriensis in mice recently cured of a previous infection.
Oyerinde JP; Fagbenro-Beyioku AF; Jaji BE
Afr J Med Med Sci; 1988 Jun; 17(2):97-100. PubMed ID: 2843024
[TBL] [Abstract][Full Text] [Related]
26. Glucose transport in cerebral microvessels during Plasmodium yoelii nigeriensis infection in mice.
Agrawal A; Pandey VC
J Commun Dis; 2000 Jun; 32(2):109-16. PubMed ID: 11198395
[TBL] [Abstract][Full Text] [Related]
27. Catalase activity in red cell and liver of mice infected with Plasmodium berghei.
Areekul S; Boonme Y
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):48-52. PubMed ID: 3526580
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
29. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Pandey VC
Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
[TBL] [Abstract][Full Text] [Related]
30. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
[TBL] [Abstract][Full Text] [Related]
31. Experimental infections of Plasmodium yoelii nigeriensis in mice and rats, and hosts' reactions.
Fagbenro-Beyioku AF; Oyerinde JP
Afr J Med Med Sci; 1989 Mar; 18(1):25-32. PubMed ID: 2545080
[TBL] [Abstract][Full Text] [Related]
32. Effect of Plasmodium yoelii nigeriensis infection and chloroquine on the hepatic mixed function oxidase system of mice.
Saxena N; Saxena A; Dutta GP; Ghatak S; Pandey VC
Mol Biochem Parasitol; 1987 Jul; 24(3):283-7. PubMed ID: 3627173
[TBL] [Abstract][Full Text] [Related]
33. [Ligand spectrum of hemoglobin activity of methemoglobin-reductase and hemolytic resistance of erythrocytes during chronic exposure to nitrates].
Kiiza DA; Artiukh VP; Starodub NF; Khmel'nitskiĭ GA
Ukr Biokhim Zh (1978); 1992; 64(4):67-72. PubMed ID: 1448877
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium yoelii: a differential fluorescent technique using Acridine Orange to identify infected erythrocytes and reticulocytes in Duffy knockout mouse.
Xu L; Chaudhuri A
Exp Parasitol; 2005 May; 110(1):80-7. PubMed ID: 15804382
[TBL] [Abstract][Full Text] [Related]
35. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
36. Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.
Choury D; Leroux A; Kaplan JC
J Clin Invest; 1981 Jan; 67(1):149-55. PubMed ID: 7451647
[TBL] [Abstract][Full Text] [Related]
37. Effect of host-diet inadequacy on the course of infection of plasmodium yoelii Nigeriensis.
Fagbenro-Beyioku AF; Oyerinde JP
West Afr J Med; 1990; 9(2):124-8. PubMed ID: 2268567
[TBL] [Abstract][Full Text] [Related]
38. Nicotinamide-adenine dinucleotide-methemoglobin reductase activity in erythrocytes from cats.
Baker DC; Gaunt SD
Am J Vet Res; 1985 Jun; 46(6):1354-5. PubMed ID: 4026013
[TBL] [Abstract][Full Text] [Related]
39. Electrophoretic and functional variants of NADH-methemoglobin reductase in hereditary methemoglobinemia.
Hsieh HS; Jaffé ER
J Clin Invest; 1971 Jan; 50(1):196-202. PubMed ID: 5543874
[TBL] [Abstract][Full Text] [Related]
40. Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
Nneji CM; Adaramoye OA; Falade CO; Ademowo OG
Parasitol Res; 2013 Jul; 112(7):2619-25. PubMed ID: 23604568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
